The promyelocytic leukemia nuclear body: sites of activity?
about
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0A novel protein, Luman/CREB3 recruitment factor, inhibits Luman activation of the unfolded protein responseG2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localizationPondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection.Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection.Characterization of the requirements for localization of phytochrome B to nuclear bodies.Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patientsSUMOylation substrates in neuronal intranuclear inclusion disease.Shigella infection interferes with SUMOylation and increases PML-NB numberNeuronal intranuclear hyaline inclusion disease.Interplay between Herpesvirus Infection and Host Defense by PML Nuclear BodiesDisruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzymePML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.Deficit of heat shock transcription factor 1-heat shock 70 kDa protein 1A axis determines the cell death vulnerability in a model of spinocerebellar ataxia type 6.Herpesvirus Latency: On the Importance of Positioning Oneself.Nuclear Arc Interacts with the Histone Acetyltransferase Tip60 to Modify H4K12 Acetylation(1,2,3).Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response
P2860
Q24298207-87073438-6793-4917-B72A-283CC53A6AC2Q24317491-A20527CA-2431-4633-A17E-2B21EA54D75DQ24681594-96CA333A-0366-4217-8DB3-D105AD68E2C8Q28755220-2DCCFF96-040D-4474-B240-8264F1A3425CQ30475799-056CC08C-D28F-4018-8A5F-0AD7201646F4Q30834143-294A52D9-6AB2-4D39-8220-C02E67AA6D2CQ33718079-365C521C-EA72-4474-A008-A677FA8027F6Q34267949-F8E38478-2959-4B17-AA5E-4AE634F4D07BQ34484119-2DAA0344-7430-4904-8EF3-0BD41013A2C4Q35596115-6EE0B621-C7CF-49D9-AA47-59EFB7A103CEQ35627286-2A47E0C0-AC46-4E6C-8C61-619A7C0EC919Q37945188-B55A48D0-0EB5-4F65-A716-F2541CDABE8DQ38563262-B79B536F-5980-43D9-A45C-1CFB5810486DQ39617826-314F7300-CF8E-4D7C-B12C-B5600449B444Q39789392-98504D51-2B4D-46E7-A95D-0FDFC77C1AC3Q40192261-EFEE9F82-DF31-4DCD-965E-38E30B7A4C2DQ41189073-09E13148-E630-49C3-B56F-9638C9E8B332Q42040593-104B788B-C7E5-4753-8AE7-606B43F54103
P2860
The promyelocytic leukemia nuclear body: sites of activity?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The promyelocytic leukemia nuclear body: sites of activity?
@ast
The promyelocytic leukemia nuclear body: sites of activity?
@en
The promyelocytic leukemia nuclear body: sites of activity?
@nl
type
label
The promyelocytic leukemia nuclear body: sites of activity?
@ast
The promyelocytic leukemia nuclear body: sites of activity?
@en
The promyelocytic leukemia nuclear body: sites of activity?
@nl
prefLabel
The promyelocytic leukemia nuclear body: sites of activity?
@ast
The promyelocytic leukemia nuclear body: sites of activity?
@en
The promyelocytic leukemia nuclear body: sites of activity?
@nl
P2860
P356
P1476
The promyelocytic leukemia nuclear body: sites of activity?
@en
P2093
Christopher H Eskiw
David P Bazett-Jones
P2860
P304
P356
10.1139/O02-079
P577
2002-01-01T00:00:00Z